|
ZNF442 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.04440000670803E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.16280000001168E-06 |
| Normal-vs-Stage2 |
3.979000E-04 |
| Normal-vs-Stage3 |
5.68739999984302E-07 |
| Normal-vs-Stage4 |
3.84020000243623E-08 |
| Stage1-vs-Stage2 |
5.041600E-01 |
| Stage1-vs-Stage3 |
1.169690E-02 |
| Stage1-vs-Stage4 |
3.821100E-04 |
| Stage2-vs-Stage3 |
1.538630E-01 |
| Stage2-vs-Stage4 |
2.054300E-02 |
| Stage3-vs-Stage4 |
3.093600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.18879999972444E-09 |
| Normal-vs-AfricanAmerican |
5.585800E-04 |
| Normal-vs-Asian |
1.715150E-03 |
| Caucasian-vs-AfricanAmerican |
8.829800E-02 |
| Caucasian-vs-Asian |
1.400160E-01 |
| AfricanAmerican-vs-Asian |
6.636000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.3952000362022E-09 |
| Normal-vs-Female |
2.15159999999992E-05 |
| Male-vs-Female |
6.461600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.39620000000085E-05 |
| Normal-vs-Extreme_Weight |
5.93929999959109E-07 |
| Normal-vs-Obese |
2.46210000000024E-05 |
| Normal-vs-Extreme_Obese |
6.835500E-03 |
| Normal_Weight-vs-Extreme_Weight |
8.286000E-01 |
| Normal_Weight-vs-Obese |
4.979800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.739200E-01 |
| Extreme_Weight-vs-Obese |
5.511800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.668800E-01 |
| Obese-vs-Extreme_Obese |
6.484800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.27269999994751E-07 |
| Normal-vs-Age(41-60Yrs) |
2.40989999999996E-05 |
| Normal-vs-Age(61-80Yrs) |
2.50289999836895E-08 |
| Normal-vs-Age(81-100Yrs) |
6.98270000043522E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.519900E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.039040E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.405000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.715990E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.040700E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.566620E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.72158999999228E-05 |
| Normal-VS-Type2 PRCC |
4.61970000031897E-08 |
| Normal-VS-KIRP CIMP |
8.66099969520917E-10 |
| Normal-VS-Unclassified PRCC |
1.245880E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.56300000006848E-08 |
| Type1 PRCC-VS-KIRP CIMP |
3.27060000004931E-06 |
| Type1 PRCC-VS-Unclassified PRCC |
2.266800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.063950E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.284020E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.49469999999264E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.61290000022518E-07 |
| Normal-vs-N1 |
5.51400000103897E-08 |
| Normal-vs-N2 |
5.4720999953517E-08 |
| N0-vs-N1 |
3.140200E-01 |
| N0-vs-N2 |
2.760200E-02 |
| N1-vs-N2 |
1.075610E-01 |
|
|
